177 related articles for article (PubMed ID: 9017687)
1. [Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].
Inatomi N; Murakami I; Asano S; Inada I; Satoh H
Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):333-43. PubMed ID: 9017687
[TBL] [Abstract][Full Text] [Related]
2. [Effects of lansoprazole on indomethacin-induced gastric bleeding and mucosal lesions in rats].
Murakami I; Asano S; Yukishige K; Nagaya H; Satoh H; Inatomi N
Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):323-32. PubMed ID: 9017686
[TBL] [Abstract][Full Text] [Related]
3. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Nagaya H; Inatomi N; Satoh H
Jpn J Pharmacol; 1991 Apr; 55(4):425-36. PubMed ID: 1886288
[TBL] [Abstract][Full Text] [Related]
4. Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats.
Inatomi N; Nagaya H; Takami K; Shino A; Satoh H
Jpn J Pharmacol; 1991 Apr; 55(4):437-51. PubMed ID: 1886289
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
Takeda H; Hokari K; Asaka M
J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
7. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
[TBL] [Abstract][Full Text] [Related]
8. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion.
Blum RA; Shi H; Karol MD; Greski-Rose PA; Hunt RH
Clin Ther; 1997; 19(5):1013-23. PubMed ID: 9385488
[TBL] [Abstract][Full Text] [Related]
9. Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.
Nishino M; Sugimoto M; Kodaira C; Yamade M; Uotani T; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
J Clin Pharmacol; 2011 Jul; 51(7):1079-86. PubMed ID: 20663999
[TBL] [Abstract][Full Text] [Related]
10. A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery.
Nishina K; Mikawa K; Maekawa N; Takao Y; Shiga M; Obara H
Anesth Analg; 1996 Apr; 82(4):832-6. PubMed ID: 8615506
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin analog prevents stress-induced expression of immediate early genes and gastric mucosal lesions in the rat stomach.
Saika M; Ueyama T; Senba E
Life Sci; 1999; 64(21):PL235-40. PubMed ID: 10353594
[TBL] [Abstract][Full Text] [Related]
12. In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity.
Arnestad JS; Kleveland PM; Waldum HL
Aliment Pharmacol Ther; 1997 Apr; 11(2):355-8. PubMed ID: 9146775
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent eradication of Helicobacter pylori with dual therapy.
Treiber G; Ammon S; Klotz U
Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
[TBL] [Abstract][Full Text] [Related]
14. Role of capsaicin-sensitive sensory neurons and nitric oxide in the protective effect of lansoprazole, a proton pump inhibitor, on the gastric mucosa in rats.
Murakami I; Satoh H; Asano S; Maeda R
Jpn J Pharmacol; 1996 Oct; 72(2):137-47. PubMed ID: 8912915
[TBL] [Abstract][Full Text] [Related]
15. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
Spencer CM; Faulds D
Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
[TBL] [Abstract][Full Text] [Related]
16. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
17. Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
Szabó IL; Czimmer J; Szolcsányi J; Mózsik G
Curr Pharm Des; 2013; 19(1):84-9. PubMed ID: 22946903
[TBL] [Abstract][Full Text] [Related]
18. Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine.
Tsuji S; Kawano S; Higashi T; Mukuda T; Imaizumi T; Tatsumi T; Miura N; Miyajima K; Fukuda M; Noguchi M
J Clin Gastroenterol; 1995; 20 Suppl 2():S1-4. PubMed ID: 7594320
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
Yamaguchi Y; Katsumi N; Tauchi M; Toki M; Nakamura K; Aoki K; Morita Y; Miura M; Morozumi K; Ishida H; Takahashi S
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():111-5. PubMed ID: 15943857
[TBL] [Abstract][Full Text] [Related]
20. Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.
Blandizzi C; Natale G; Gherardi G; Lazzeri G; Marveggio C; Colucci R; Carignani D; Del Tacca M
Dig Dis Sci; 1999 Oct; 44(10):2039-50. PubMed ID: 10548356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
